Home » General World News » Valeant shares hit 2017 high following Dendreon sale

Valeant shares hit 2017 high following Dendreon sale





Shares in Valeant Pharmaceuticals hit a new high for the year on the Toronto Stock Exchange this morning after the company completed the sale of its Dendreon subsidiary for US$819.9 million cash. read more >>>

Source:: CTVNews.Ca

Comments are closed.